Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.
暂无分享，去创建一个
A. Nagler | C. Denzlinger | G. Rossi | B. Afanasyev | U. Platzbecker | M. Mittelman | R. Wong | A. Anagnostopoulos | B. Brenner | D. Selleslag | Zewen Zhu | S. Grosicki | R. García-Delgado | M. S. Portella